Senior Vice President, Head of Medical Affairs, Biopharma & Women's Health
Sumitomo Pharma America
Bridgewater, New Jersey, United States
Health Outcomes Risk by Incremental Anticholinergic Burden in Overactive Bladder
Thursday, October 24, 2024
4:38 PM – 4:42 PM EDT
Disclosure(s): Sumitomo Pharma America: Employee (Terminated, March 31, 2024)